Unverified50% confidenceFactExact time
The mechanism of action of lecanemab and donanemab is to target and clear abnormally accumulated β-amyloid plaques in the brain, and both belong to monoclonal antibody therapies
1
Sources
50%
Confidence
Long-term
Relevance
9/17/2026
First Seen
Sources
Related Entities
Related Claims
Unverified蓝斑核是大脑中去甲肾上腺素的主要来源58% similarUnverified高浓度CO2引发血液轻度酸化，破坏GABA与谷氨酸等神经递质平衡，抑制前额叶皮层的执行功能55% similarUnverifiedT1-CE achieves signal enhancement through leakage of gadolinium-based contrast agent in regions where the blood-brain barrier is disrupted after contrast injection, highlighting active tumor regions.54% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/928900API
curl https://kongchang.com/api/v1/knowledge/claims/928900MCP
get_claim(id=928900)